Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo - Test2 - elhamkhani - TriplyDB

Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo

Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo

http://www.wikidata.org/entity/Q28214688

about

sameAs

Ketogenic Diets: An Update for Child Neurologists The ketogenic diet: uses in epilepsy and other neurologic illnesses The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies Neuroprotective and disease-modifying effects of the ketogenic diet A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype The neuropharmacology of the ketogenic diet The ketogenic diet in a pill: is this possible?Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.Dietary approaches to epilepsy treatment: old and new options on the menu.The ketogenic diet: proposed mechanisms of action.Ketogenic diets: evidence for short- and long-term efficacy.The ketogenic diet for the treatment of epilepsy: a challenge for nutritional neuroscientists.Purines and the Anti-Epileptic Actions of Ketogenic Diets.Ketogenic diets, mitochondria, and neurological diseases.Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester.A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.Use of the ketogenic diet as a treatment for epilepsy refractory to drug treatment.The ketogenic diet: metabolic influences on brain excitability and epilepsy.Progress in neuroprotective strategies for preventing epilepsy.Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies.What constitutes a relevant animal model of the ketogenic diet?Ketone bodies, glycolysis, and KATP channels in the mechanism of the ketogenic diet The metamorphosis of the developing cerebellar microcircuit.Excitatory action of GABA on immature neurons is not due to absence of ketone bodies metabolites or other energy substrates.Neuroprotection in metabolism-based therapy.Ketone bodies in epilepsy Anticonvulsant Effects of β-Hydroxybutyrate in Mice.The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action.The Anticonvulsant Effects of Ketogenic Diet on¬ Epileptic Seizures and Potential Mechanisms.Proconvulsant effects of the ketogenic diet in electroshock-induced seizures in mice.Substantia(ting) ketone body effects on neuronal excitability Novel aspect of ketone action: β-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro.The anticonvulsant activity of acetone does not depend upon its metabolites.Impact of dietary fats on brain functions.Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?Ketone Bodies as Anti-Seizure Agents.Efficacy and tolerability of the ketogenic diet according to lipid:nonlipid ratios--comparison of 3:1 with 4:1 diet.Neuronal inhibition and seizure suppression by acetoacetate and its analog, 2-phenylbutyrate.Energy substrates protect hippocampus against endogenous glutamate-mediated neurodegeneration in awake rats.Editorial: Recent Advances in Pathophysiological Studies and Treatment of Epilepsy.

P2860

Q22299266-3D77EB4F-30E1-4447-BA3D-F32E531D1922 Q24617926-DFBC098C-0139-4420-BD4A-0D45C697CF9A Q24646616-039CBBD9-4D15-4DD9-A10B-92C1E0A812F0 Q24646914-C6BAE236-9E9B-4A49-9B7A-0AF2023339AA Q24650359-AF01103F-B0BD-4898-95C7-5459CFAA68B0 Q24681728-8675C529-2EDC-4023-8FFE-6F103F7818E7 Q33346385-B3BA114D-FEB1-46B9-9416-F81527C162A6 Q33569276-D925C07A-0665-45D2-B911-2C626F0FDAF9 Q33899468-2861E51E-3FB3-4619-8B27-A88EB3309B8E Q34971363-A11AAEA4-2EB1-4D7E-BF71-646A3C850F0B Q34971377-0A0F6510-91F4-442C-9100-5937998B9DE1 Q35117887-C8B55911-1694-415D-B41B-0C154BBBBDA7 Q35513799-CEF16598-8570-4B2E-B74A-DDA7589DC8A2 Q36196765-2CC698EF-5100-4524-98E2-75073088710C Q36197639-8EFE6738-D1F3-41AB-8AB6-64C5236D9918 Q36255606-1E4711A7-6F25-43FB-9BD6-1851191B74C4 Q36307861-F62F9F36-4C76-41EE-88F6-1C1C20E236AF Q36501202-3E3273A8-2009-4AC9-A8CA-D9BA3C91621A Q36739694-71A4096E-1F24-474E-9001-7E0C0E537F79 Q36954084-37B91BD1-0F97-419C-AEC0-ED9697BA12F0 Q37339269-18415966-3A2C-4E83-872E-43802F3221CB Q37339292-A7163DBA-8381-41BF-8885-FD3B930F7CE3 Q37847374-5B47DA9B-1EAB-4EED-AC46-FAA1FA03B126 Q37892605-34F67B40-6059-40E9-8DCC-8BA163A4C9A2 Q37923014-DDE8090F-C2B9-46C1-8E82-A0FAF5F5E11C Q37978003-BB3E871F-F47D-41F6-815A-C2D27049786B Q38263584-86192562-F806-4F1B-9307-9F126DDBBFC8 Q38495538-698147C1-EB95-40D2-BF34-A90672471FD0 Q38682179-98113E05-5803-4FAF-BA1A-D41DE27EAD5A Q42317046-7AC07069-5579-43A0-A954-3DE0256D16B1 Q42627066-45306036-4F78-4124-8C59-57001140E625 Q43491632-9BE2D183-5E75-4038-AE1F-409F22E6CD5E Q46613377-D7ECF89A-B7B3-4DBE-8142-27E1DCFF70A1 Q47290017-CB57C7FC-0EBB-4E93-B7D7-FB6C49D624EE Q47869408-FE7909F8-D95F-40F2-9EC9-29C7AC518B07 Q47923460-A3C7E670-1038-486F-9F91-B263B16B5865 Q48228351-BE83617E-8FF4-4536-8D94-858B543F7C2E Q48263017-2EA2BC0B-D549-4C7D-8869-ADFBADF01D35 Q48800243-2450792A-E824-4B5B-B714-AA9F94986B61 Q50189503-DA92F958-123D-4A8D-8471-9AED40318C1A

P2860

Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo

http://www.wikidata.org/entity/Q28214688

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@ast

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@en

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@nl

type

label

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@ast

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@en

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@nl

prefLabel

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@ast

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@en

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@nl

P1433

Q28214688-FA0524E6-E338-4323-8A64-D0D9C0318102

P1476

Q28214688-3136A000-F366-47D7-835F-1CED5AA25220

P2093

Q28214688-267F9C0D-E9EB-4FE8-9636-BC995FBD7642

Q28214688-9166A556-CD1D-4077-93A6-BD1BFBC8A889

Q28214688-ADD385B0-7E80-4464-A5A7-850872F55384

Q28214688-D937547E-D368-4B29-BE4D-D97055368B42

P2860

Q28214688-32071201-BF04-49A8-AF34-C171A75B5034

Q28214688-369C50A4-EC91-4A3E-AECA-BCDC843C08B5

Q28214688-40652AAD-60A6-4F46-AFAB-6D360B4D160D

Q28214688-5156CA8B-D0AC-4319-9088-F581517B77DC

Q28214688-55179AE7-E9AC-40FF-8288-BCF3A5928741

Q28214688-5A1DCA15-2DE8-4069-A6E5-56F58C7D0910

Q28214688-691F7F3C-CF9A-4D3D-A70E-530D25AF8E47

Q28214688-ADD2CA2D-F602-445A-98A6-E5B5773190E7

Q28214688-D42CC212-A85A-46FE-8101-E2DCF752661A

Q28214688-E85B7319-9619-4B51-8F75-DFA6176587A1

P304

Q28214688-C6622613-C3AA-4B09-AAA1-FDC451DC61CA

P31

Q28214688-E6A9C514-CC86-42AA-8889-0984F0647BCF

P356

Q28214688-3B772E1D-35D2-4294-B42F-ECD73947716E

P407

Q28214688-7294BC90-0D62-46D0-8D49-2C0D22E3C274

P433

Q28214688-2111F685-5626-4D7E-9160-E76A696A6D29

P478

Q28214688-E7BD5C73-9010-4C08-B089-A26D6B334E7A

P577

Q28214688-341BBC6C-19D9-452B-9D88-BC28F636D1F8

P698

Q28214688-432B2C86-8C9C-4E7E-8696-45F36C734F39

P356

J.1528-1157.2002.47901.X

P1433

P1476

Acetoacetate, acetone, and dib ...... anticonvulsant actions in vivo

@en

P2093

Gail D Anderson

http://www.w3.org/2001/XMLSchema#string

H Steve White

http://www.w3.org/2001/XMLSchema#string

Jong M Rho

http://www.w3.org/2001/XMLSchema#string

Sean D Donevan

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification

Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy.

A multicenter study of the efficacy of the ketogenic diet.

The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children.

Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis.

Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain.

The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones.

Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission.

Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites.

3-hydroxybutyrate blocks the transient K+ outward current in myocardial mouse cells in a stereoselective fashion.

P304

358-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1528-1157.2002.47901.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11952765

http://www.w3.org/2001/XMLSchema#string